Ocular Toxicity of Commercially Available Belantamab Mafodotin in Patients with Advanced Multiple Myeloma

被引：1
|
作者：
Abeykoon, Jithma P. [1 ]
Vaxman, Luliana [2 ]
Patel, Sanjay V. [2 ]
Kumar, Shaji [3 ]
Young, Kimberly S. [2 ]
Ailawadhi, Sikander [4 ]
Larsen, Jeremy T. [5 ]
Gonsalves, Wilson I. [6 ]
Kourelis, Taxiarchis [1 ]
Leung, Nelson [7 ]
Warsame, Rahma M. [1 ]
Hobbs, Miriam A. [1 ]
Fonder, Amie [1 ]
Hwa, Yi L. [1 ]
Bergsage, P. Leif [8 ]
Lacy, Martha Q. [6 ]
kumar, S. Vincent Raj [1 ]
Gertz, Morie A. [1 ]
Kapoor, Prashant [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Rochester, NY USA
[3] Mayo Clin, Rochester, MN USA
[4] Mayo Clin, Div Hematol, Jacksonville, FL USA
[5] Mayo Clin, Div Hematol, Phoenix, AZ USA
[6] Mayo Sch Grad Med Educ, Div Hematol, Rochester, MN USA
[7] Mayo Clin Rochester, Div Hematol, Rochester, MN USA
[8] Mayo Clin, Div Hematol, Scottsdale, AZ USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-154183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myeloma
    Abeykoon, Jithma P.
    Vaxman, Julia
    Patel, Sanjay V.
    Kumar, Shaji
    Malave, Gabriella C.
    Young, Kimberly S.
    Ailawadhi, Sikander
    Larsen, Jeremy T.
    Dispenzieri, Angela
    Muchtar, Eli
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Leung, Nelson
    Warsame, Rahma
    Go, Ronald S.
    Bergsagel, Leif
    Lacy, Martha Q.
    Rajkumar, S. Vincent
    Gertz, Morie A.
    Kapoor, Prashant
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (01) : 95 - 99
  • [2] Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma
    Wahab, Ahsan
    Rafae, Abdul
    Mushtaq, Kamran
    Masood, Adeel
    Ehsan, Hamid
    Khakwani, Maria
    Khan, Aqsa
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Belantamab mafodotin in multiple myeloma
    Martino, Enrica Antonia
    Bruzzese, Antonella
    Iaccino, Enrico
    Labanca, Caterina
    Mendicino, Francesco
    Mimmi, Selena
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (11) : 1043 - 1047
  • [4] Adverse ocular events related to belantamab mafodotin for treatment of multiple myeloma
    Lent-Schochet, Daniella
    Mokhashi, Nikita
    Vidyasagar, Nitin
    Farooq, Asim
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [5] Belantamab mafodotin for the treatment of multiple myeloma
    Wang, B.
    Wu, C.
    Zhong, Q.
    Ling, L.
    Wu, Z.
    Yu, B.
    Gao, X.
    Zeng, H.
    Yang, D-H
    DRUGS OF TODAY, 2021, 57 (11) : 653 - 663
  • [6] BELANTAMAB MAFODOTIN IN A PATIENT WITH REFRACTORY MULTIPLE MYELOMA
    Luz Gema, Roman
    Borja, Puertas
    Alberto, Hernandez
    Sandra, Gomez
    Felipe, Pena
    Danylo, Palomino
    Bea, Rey
    Marta, Fonseca
    Raul, Azibeiro
    Elena, Alejo
    David, Alonso
    Jose Maria, Navarro
    Veronica, Gonzalez
    Noemi, Puig
    Maria Victoria, Mateos
    HAEMATOLOGICA, 2021, 106 (10) : 334 - 334
  • [7] Corneal Changes After Belantamab Mafodotin in Multiple Myeloma Patients
    Bausell, Rebecca B.
    Soleimani, Arshia
    Vinnett, Alfred
    Baroni, Mariana D.
    Staub, Sheila A.
    Binion, Katrina
    Jeng, Bennie H.
    Badros, Ashraf Z.
    Munir, Wuqaas M.
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2021, 47 (06): : 362 - 365
  • [8] The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma
    Becnel, Melody R.
    Lee, Hans C.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [9] Belantamab mafodotin for relapsed or refractory multiple myeloma
    David Gil-Sierra, Manuel
    del Pilar Briceno-Casado, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (06) : 1375 - 1380
  • [10] Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
    Hungria, Vania
    Robak, Pawel
    Hus, Marek
    Zherebtsova, Vera
    Ward, Christopher
    Ho, P. Joy
    Ribas de Almeida, Ana Carolina
    Hajek, Roman
    Kim, Kihyun
    Grosicki, Sebastian
    Sia, Hanlon
    Bryant, Adam
    Pitombeira de Lacerda, Marcelo
    Aparecida Martinez, Gracia
    Sureda Balari, Anna Maria
    Sandhu, Irwindeep
    Cerchione, Claudio
    Ganly, Peter
    Dimopoulos, Meletios
    Fu, Chengcheng
    Garg, Mamta
    Abdallah, Al-Ola
    Oriol, Albert
    Gatt, Moshe E.
    Cavo, Michele
    Rifkin, Robert
    Fujisaki, Tomoaki
    Mielnik, Michal
    Pirooz, Nick
    Mckeown, Astrid
    Mcnamara, Simon
    Zhou, Xiangdong
    Nichols, Maureen
    Lewis, Eric
    Rogers, Rachel
    Baig, Hena
    Eccersley, Lydia
    Roy-Ghanta, Sumita
    Opalinska, Joanna
    Mateos, Maria-Victoria
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (05): : 393 - 407
12345